Fig. 2From: Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapyOverview of the current challenges and future optimizations of ADCs. A Mechanism underlying the adverse effects of ADCs and optimizing strategies. B Resistant mechanisms of ADC and optimizing strategiesBack to article page